Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2014


CE in the Biotechnology & Pharmaceutical Industries 2014

12 Oct 2014 - 16 Oct 2014 - Seattle, WA, USA



Bookmark and Share


16th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules

Top 10 Reasons to Attend CE Pharm 2014

 1.   Meet the highest concentration of industry/pharma CE experts under one roof.

 2.   Perspectives and guidance from regulatory agency experts.

 3.   Troubleshooting in CE beyond manuals.

 4.   Open atmosphere for discussions; problems are named and solutions discussed openly.

 5.   Networking with CE experts from industry, health authorities and academia.

 6.   Vendor independent insight in CE hardware.

 7.   Excellent short courses on fundamentals, good practice and protein applications.

 8.   Get innovative ideas for new applications.

 9.   Update on new technologies and industrial applications in CE.

 10. Learning about results of and opportunities to participate in inter-company collaborations to study the robustness of the CE methods.

The symposium provides an interactive forum for the discussion of recent development and practical applications of capillary electrophoresis (CE) in the pharmaceutical and biotechnology industries, including regulatory considerations. 

The forum also provides a venue for industrial CE practitioners to meet, network and participate in exchanging knowledge for mutual education.  For more information, go to www.casss.org. 




Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!